93 results
6-K
EX-99.1
BPTSY
Biophytis S.A.
2 Nov 23
Biophytis and Innovation Solutions Pharma sign a partnership agreement to accelerate market access for Sarconeos (BIO101) in Brazil
2:44pm
in Brazil.
Authorization to use the product is granted on request, and only under the responsibility of the prescribing practitioner, as it is likely
6-K
EX-99.1
BPTSY
Biophytis S.A.
27 Sep 23
Half-year Financial Report
5:00pm
statements of Biophytis, or the “Financial Statements”, have been prepared under the responsibility of management of the Company and were approved
F-1
EX-3.1
BPTSY
Biophytis S.A.
4 Aug 23
Registration statement (foreign)
4:18pm
Organisational principles
In accordance with the legal provisions, the general management of the Company is carried out under his responsibility, either
6-K
EX-10.2
BPTSY
Biophytis S.A.
21 Jul 23
Biophytis Announces $3.8 Million
6:01am
current, future or contingent liability or responsibility, has been maintained in compliance with its terms and the requirements of any applicable
424B5
tya6s
20 Jul 23
Prospectus supplement for primary offering
5:27pm
20-F/A
btvseocpftnhytu
3 Jul 23
Annual report (foreign) (amended)
4:15pm
F-3
EX-4.6
2zqha7w55fynlzv
21 Apr 23
Shelf registration (foreign)
4:16pm
F-3
EX-5.2
rp0fa
21 Apr 23
Shelf registration (foreign)
4:16pm
F-3
xo6f1rv
21 Apr 23
Shelf registration (foreign)
4:16pm
6-K
EX-99.1
n2jzh2de2tv6otx
3 Feb 22
Biophytis received approval from ANVISA (Brazil) to give
11:43am
6-K
EX-99.1
nf8rb99fr
28 Oct 21
Half-year Financial Report
5:18pm
20-F/A
7qwndmx70q
28 Oct 21
Annual report (foreign) (amended)
5:16pm
20-F
EX-4.36
xz3fpgzw
12 Mar 21
Annual report (foreign)
2:38pm